Cardiovascular disease and multifactorial risk: challenge of the 1980s

American Heart Journal
|November 1, 1983
PubMed

Insights

This study reviews atherosclerotic cardiovascular disease risk factors over 18 years. It offers physicians two tools for multifactorial risk management, aiding in identifying high-risk patients.

Area of Science:

  • Cardiovascular Medicine
  • Epidemiology
  • Preventive Cardiology

Background:

  • Atherosclerotic cardiovascular diseases (ASCVD) represent a major global health burden.
  • Understanding the natural history and risk factors of ASCVD is crucial for effective prevention.
  • The Framingham Heart Study provides long-term data on cardiovascular disease development.

Purpose of the Study:

  • To review the natural history of ASCVD based on risk factor parameters.
  • To emphasize the importance of a multifactorial approach in managing cardiovascular risk.
  • To introduce practical tools for physicians to assess and manage patient risk.

Main Methods:

  • Analysis of 18-year risk factor data from the Framingham Heart Study population.
  • Development of a precise numerical risk evaluation system using five key parameters.
  • Inclusion of high-density lipoprotein cholesterol as a multiplier in the numerical system.
  • Creation of a simplified categorical checklist with cutoff values for risk factors.

Main Results:

  • Identification of key risk factor parameters influencing the natural history of ASCVD.
  • Validation of a numerical risk assessment tool incorporating total cholesterol, systolic blood pressure, diabetes mellitus, left ventricular hypertrophy, and smoking.
  • Introduction of a high-density lipoprotein cholesterol multiplier for enhanced risk precision.
  • Development of a user-friendly categorical checklist for rapid risk stratification.

Conclusions:

  • A multifactorial approach is essential for effective management of cardiovascular risk factors.
  • The proposed numerical evaluation system provides a precise method for calculating ASCVD risk.
  • The categorical checklist offers a practical, easily memorized tool for identifying high-risk patients.
  • These tools can aid physicians in proactive risk factor management and patient care.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...